Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder

NCT03017508 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Social Anxiety Disorder
Performance Anxiety

Interventions

DRUG: BHV-0223
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]